Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Central South University
Affiliated withCentral South UniversityShandong First Medical University & Shandong Academy of Medical Science
Research Area
Xianquan Zhan received his M.D. and Ph.D. training in preventive medicine at West China University of Medical Sciences during 1989-1999. He received his post-doctoral training in oncology and cancer proteomics at Central South University and University of Tennessee Health Science Center (UTHSC). He worked at UTHSC and Cleveland Clinic in USA during 2001-2012, and achieved the rank of Associate Professor at UTHSC. In 2012, he moved to Central South University Xiangya Hospital as a Professor, and Advisors of MS/PhD graduate students and postdoctoral fellows. He is also the Fellow of Royal Society of Medicine, Fellow of EPMA, European EPMA National Representative, AAAS member, Editor-In-Chief of IJCDT, Execute Editor-in-Chief of Med One, Associate Editors of EPMA Journal and BMC Medical Genomics, and Guest Editors of Frontiers in Endocrinology (IF = 3.65) and Mass Spectrometry Reviews (IF = 9.068). He has published 130 articles, 16 book chapters, 3 books, and 2 US patents in the field of clinical proteomics and biomarkers. His research interests focus on the development and use of multi-omics (genomics, transcriptomics, proteomics, metabolomics, and radiomics) and systems biology to study cancer mechanisms, and discover effective biomarker pattern for predictive, preventive, and personalized medicine (PPPM) or precission medicine (PM) in cancer, and also focus on cancer proteoforms and post-translational modifications (PTMs).
Article Total : 3 | Year |
|---|---|
![]() Publication title Cited by 18 | 2018 |
![]() Publication title Cited by 3 | 2019 |
| 2026 |